|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 5.500 USD | +13.64% |
|
+29.06% | +149.32% |
EPS & Dividend: Immix Biopharma, Inc.
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|
| Dividend per Share 2 | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - |
| EPS 2 | -6.64 | -0.59 | -0.89 | -0.76 | -0.79 | -0.73 |
| Distribution rate | - | - | - | - | - | - |
| Reference price 2 | 3.560 | 2.290 | 6.920 | 2.200 | 4.840 | 4.840 |
| Nbr of stocks (in thousands) | 13,209 | 13,927 | 19,867 | 27,508 | 33,578 | - |
| Announcement Date | 3/28/22 | 3/27/23 | 3/29/24 | 3/25/25 | - | - |
1USD in Million2USD
Estimates
Upcoming events: Immix Biopharma, Inc.
| 2025-12-07 05:45 pm | American Society of Hematology Meeting - Abstract Number: 25-14730 |
| Dividend Yield (Y) | Dividend Yield (Y+1) | P/E (Y) | Price to Book (Y) | EV / Sales (Y) | ||
|---|---|---|---|---|---|---|
 | - | - | -6.13x | - | - | |
| -.--% | -.--% | 51.47x | 8.37x | 12.55x | |
| -.--% | -.--% | -33.26x | 66.46x | 84.43x | |
| 1.79% | 1.69% | 15.85x | 3.74x | 5.55x | |
| -.--% | -.--% | -25.43x | 1.1x | 3.36x | |
| -.--% | -.--% | 17.63x | 3.33x | 4.35x | |
| -.--% | -.--% | 27.78x | 2.57x | 5.44x | |
| -.--% | -.--% | -14.56x | - | 183.27x | |
| -.--% | -.--% | -510.49x | 13.99x | 29.53x | |
| -.--% | -.--% | -59.75x | 22.06x | 13.44x | |
| Average | 0.2% | 0.19% | -53.69x | 15.20x | 37.99x | |
| Weighted average by Cap. | 0.28% | 0.27% | -25.57x | 18.36x | 33.79x |
Dividend / Share (DPS) - Evolution of Analysts' Estimates
Dividend / Share (DPS) - Estimates Revisions
Earnings Per Share (EPS) - Evolution of Analysts' Estimates
Annual Profit -
Select your edition
All financial news and data tailored to specific country editions
